CT nursing home COVID deaths, infections decline as more get vaccinated
Dave Altimari, CTMirror.org
FacebookTwitterEmail
Mary Lou Galushko gives Jeanne Peters, 95, a rehab patient at The Reservoir, a nursing facility, the first COVID-19 vaccination at the nursing home Friday, Dec. 18, 2020, in West Hartford, Conn.Stephen Dunn / Associated Press
For the first time in several weeks, the number of COVID-19 deaths and infections in long-term care facilities in Connecticut decreased sharply raising the possibility that systematic vaccinations are curbing the virus’s deadly path through the state’s most vulnerable residents.
Over the week of Jan. 6-12, there were 85 deaths in nursing homes and 312 residents who were infected both numbers lower than during previous weeks. For the period of Dec. 30 to Jan. 5, there were 120 deaths due to COVID-19 and 483 infections. The week before, there were 126 deaths and 382 infections.
CT nursing home COVID deaths, infections decline as more get vaccinated
Dave Altimari, CTMirror.org
FacebookTwitterEmail
Mary Lou Galushko gives Jeanne Peters, 95, a rehab patient at The Reservoir, a nursing facility, the first COVID-19 vaccination at the nursing home Friday, Dec. 18, 2020, in West Hartford, Conn.Stephen Dunn / Associated Press
For the first time in several weeks, the number of COVID-19 deaths and infections in long-term care facilities in Connecticut decreased sharply raising the possibility that systematic vaccinations are curbing the virus’s deadly path through the state’s most vulnerable residents.
Over the week of Jan. 6-12, there were 85 deaths in nursing homes and 312 residents who were infected both numbers lower than during previous weeks. For the period of Dec. 30 to Jan. 5, there were 120 deaths due to COVID-19 and 483 infections. The week before, there were 126 deaths and 382 infections.
(1)
UV-C Disinfecting Device Used in Hospitals Globally Achieves 99.99% Inactivation of SARS-CoV-2 in BSL-3 Laboratory Testing
UltraViolet Devices, Inc. (UVDI) announced its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters). Testing on the coronavirus strain that causes the COVID-19 disease was conducted by Innovative Bioanalysis, a CAP, CLIA, and BEI-recognized BSL-3 certified laboratory (CA, USA). The Centers for Disease Control and Prevention (CDC) has indicated that the COVID-19 disease can be spread by both surface and airborne transmission of SARS-CoV-2.
1
The UVDI-360 Room Sanitizer is used in approximately 1,000 hospitals globally. (Photo: Business Wire)
Policy brief shows support for antibiotic development incentives
Interviews with policymakers and antimicrobial resistance (AMR) experts from 13 countries indicate broad support for financial incentives to boost antibiotic development, despite uncertainty over which incentives are appropriate and how much they ll cost, according to a policy brief released yesterday by the European Union Joint Action Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI) and the Global AMR Research and Development Hub.
In the interviews, which were conducted to better understand perceptions of antibiotic development incentives and barriers to implementing them, 11 of 13 interviewees expressed high-level, general support for incentive programs. But before selecting a type of incentive, they said they prefer to wait for evidence from the three countries United Kingdom, Germany, and Sweden currently testing pull incentives models that aim to increase revenues for antibiotics whil
Vaccines a shot in the arm for a state burdened by COVID-19
December 23, 202010:46 am FIRST TO VOLUNTEER: The first to get the Pfizer vaccine at UAMS was medical assistant Yolanda Emery. Bryan Clifton, UAMS
Along with the Baby Yoda plush dolls, Gravity Blankets and Ninja Air Fryers loaded on UPS and FedEx planes and trucks this Christmas season was the most desired gift of all: COVID-19 vaccines, from manufacturers Pfizer-BioNTech and Moderna. The Pfizer vaccine, shipped in special boxes to keep doses colder than the surface of Mars, was first, arriving in Arkansas on Dec. 14.
Like other coveted presents, however, the vaccines were in short supply, so the government, with input by a panel of health experts and the nod from the governor, chose who’d be first in line: health care professionals and others who attend COVID-19 patients and staff and residents of long-term care facilities.